Freeman G J, Borriello F, Hodes R J, Reiser H, Gribben J G, Ng J W, Kim J, Goldberg J M, Hathcock K, Laszlo G
Dana-Farber Cancer Institute, Department of Medicine, Harvard Medical School, Boston, MA 02115.
J Exp Med. 1993 Dec 1;178(6):2185-92. doi: 10.1084/jem.178.6.2185.
The B7-1 molecule, expressed on antigen presenting cells (APC), provides a crucial costimulatory signal for T cell activation. Recent studies demonstrate the existence of alternative, non-B7-1 CTLA4 counter-receptors in mice and humans. Here, we describe the molecular cloning and demonstrate costimulatory function of the murine B7-2 (mB7-2) gene. Murine B7-2 cDNA encodes a member of the Ig supergene family that binds CTLA4-Ig and stains with the GL1 but not anti-mB7-1 mAb. Murine B7-2 costimulates the proliferation and interleukin 2 production of CD4+ T cells and this costimulation can be inhibited by either CTLA4-Ig or GL1 mAb. Identification of the B7-2 molecule will permit further manipulation of the B7:CD28/CTLA4 costimulatory pathway which has been shown to be involved in the prevention of tolerance, induction of tumor immunity, and most recently, in the pathogenesis of autoimmunity.
表达于抗原呈递细胞(APC)上的B7-1分子为T细胞活化提供关键的共刺激信号。最近的研究表明,在小鼠和人类中存在替代性的、非B7-1的CTLA4反受体。在此,我们描述了小鼠B7-2(mB7-2)基因的分子克隆并证明了其共刺激功能。小鼠B7-2 cDNA编码Ig超基因家族的一个成员,该成员可与CTLA4-Ig结合,并能用GL1染色,但不能用抗mB7-1单克隆抗体染色。小鼠B7-2共刺激CD4+ T细胞的增殖和白细胞介素2的产生,并且这种共刺激可被CTLA4-Ig或GL1单克隆抗体抑制。B7-2分子的鉴定将有助于进一步调控B7:CD28/CTLA4共刺激途径,该途径已被证明与预防耐受、诱导肿瘤免疫以及最近的自身免疫发病机制有关。